What is your profession?
MDNP DOOncology Nurse PhDNurse PA/PA-COther (please specify)

What Board Certifications do you have?
Med OncOncology Surgeon HematologistInternal Medicine Hem/OncFamily Practice Surgical OncOther (please specify) Radiation Onc

What is your primary specialty?
General OncologyHead, Neck, or Lung Cancers Gastrointestinal CancersGynecologic Cancer Genitourinary CancersHematological Malignancies Breast CancerOther

May we e-mail you for further clarification of your comments?
Yes No

How would you describe this course to your colleagues?

What in the program description did you find most compelling? Did your experience match your expectations?

Have you attended a prior Dana-Farber Master Class for Oncologists?
Yes No

If yes, how does this year’s program compare?

How does Dana-Farber Master Class compare to other CME programs you’ve attended?

Of the sessions currently in the course, which did you find MOST engaging? Please explain.

Which sessions did you find LEAST valuable? Please explain.

What activity or topic would you like to see in future Master Class courses? Please explain.

Please identify and provide feedback (knowledge, quality of presentation style, level of content) for each track you attended.

Please identify you how you will use information from each track in your clinical practice.

Select the tracks you attended


	Success You have claimed credit successfully. Print your certificate

October 26-27 New York, NY

Course complete: Registration is closed.

Agenda

Accreditation

Accommodations

Agenda

Friday

06:30 AM - 07:15 AM	Registration and Breakfast
07:15 AM - 07:30 AM	Opening Remarks

Genitourinary Cancers Track

07:30 AM - 08:20 AM	Advanced and Metastatic Prostate Cancer: The Evolving Therapeutic Landscape Philip W. Kantoff, MD
08:20 AM - 08:55 AM	Bladder and Renal Cancer: Individualized Approaches and Evidence-Based Best Practices Robert Dreicer, MD

Lung, Head, and Neck Cancers Track

08:55 AM - 09:45 AM	Head and Neck Cancer: Integrating Multiple Modalities Into an Individualized Approach Robert I. Haddad, MD

09:45 AM - 10:00 AM	Break

Lung, Head, and Neck Cancers Track

10:00 AM - 10:35 AM	Small Cell Lung Cancer: Current Best Practices and Emerging Clinical Data Bruce E. Johnson, MD; Track Director
10:35 AM - 11:35 AM	Non-Small Cell Lung Cancer: Implementing Recent Guidelines and Evidence-Based Best Practices Pasi A. Jänne, MD, PhD

11:35 AM - 12:05 PM	Panel Discussion
12:05 PM - 01:00 PM	Lunch

Hematologic Malignancies Track

01:00 PM - 01:50 PM	Lymphomas: Optimizing Use of the Current Therapeutic Armamentarium Arnold S. Freedman, MD; Track Director
01:50 PM - 02:45 PM	Myeloid Malignancies: Initial Therapeutic Decisions and Long Term Management
02:45 PM - 03:20 PM	Myeloproliferative Disorders: Recent Advances and Remaining Clinical Dilemmas Ayalew Tefferi, MD

03:20 PM - 03:35 PM	Break

Hematologic Malignancies Track

03:35 PM - 04:10 PM	Multiple Myeloma: Evidence-Driven Best Practices in 2012 Kenneth C. Anderson, MD
04:10 PM - 04:45 PM	Chronic Lymphocytic Leukemia: Therapeutic Choices and Ongoing Management John C. Byrd, MD

04:45 PM - 05:15 PM	Panel Discussion
05:15 PM - 05:20 PM	Program Adjournment

Optional MOC Session

06:00 PM - 08:00 PM	Optional MOC Session

Saturday

06:30 AM - 07:15 AM	Registration and Breakfast
07:15 AM - 07:30 AM	Opening Remarks

Gastrointestinal Cancer Track

07:30 AM - 08:20 AM	Esophagael, Gastric, and Pancreatic Cancers: How to Improve Survival for These Deadly Cancers Peter C. Enzinger, MD
08:20 AM - 09:05 AM	Familial Gastrointestinal Cancers: Screening, Evaluating, and Managing Patients with Hereditary Gastrointestinal Cancers Sapna Syngal, MD, MPH

09:05 AM - 09:20 AM	Break

Gastrointestinal Cancer Track

09:20 AM - 10:10 AM	Preventing the Development and the Recurrence of Gastrointestinal Cancers through Lifestyle Practices: The Influence of Diet and Lifestyle in Colorectal Cancer Charles S. Fuchs, MD, MPH
10:10 AM - 11:00 AM	Colorectal Cancers: Optimizing Therapeutic Choices in the Adjuvant and Metastatic Disease Setting Robert J. Mayer, MD; Course Chair/Track Director

11:00 AM - 11:30 AM	Panel Discussion

Gynecologic Cancer Track

11:30 AM - 12:00 PM	Ovarian Cancer: Evidence-Based Best Practices and Emerging Clinical Trial Results Ursula A. Matulonis, MD

12:00 PM - 01:00 PM	Lunch

Supportive Care Track

01:00 PM - 01:50 PM	Palliative and Supportive Care: A Comprehensive Guide to Caring for Your Patients Janet L. Abrahm, MD, FACP, FAAHPM

Breast Cancer Track

01:50 PM - 02:40 PM	High Risk Breast Cancer: The Evolving Management of High Risk Breast Cancer Patients Kenneth Offit, MD, MPH
02:40 PM - 03:30 PM	Individualized Treatment Strategies in Breast Cancer: Therapeutic Choices for HER2+, Triple Negative, and Other Subtypes Eric P. Winer, MD

03:30 PM - 03:45 PM	Break

Breast Cancer Track

03:45 PM - 04:25 PM	Hormone Receptor Positive Breast Cancer: Integrating Recent Clinical Data Into Evidence-Based Best Practices Harold J. Burstein, MD, PhD; Track Director
04:25 PM - 05:00 PM	Breast Cancer Survivorship: Treating the Whole Patient: A Comprehensive Approach to Breast Cancer Survivorship Ann H. Partridge, MD, MPH

05:00 PM - 05:30 PM	Panel Discussion
05:30 PM - 05:35 PM	Program Adjournment

© Copyright Dana-Farber Cancer Institute. All rights reserved.
This course is jointly sponsored by Dana-Farber Cancer Institute, Knowledge to Practice and Annenberg Center for Health Sciences.

For questions or more information on our live courses or online activities, please contact:
Laurie Bertoncini, Program Manager
Phone: 610-361-9720 | Email: LBertoncini@KnowledgeToPractice.org